196 related articles for article (PubMed ID: 17560798)
1. Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma.
Lin D; Najbauer J; Salvaterra PM; Mamelak AN; Barish ME; Garcia E; Metz MZ; Kendall SE; Bowers M; Kateb B; Kim SU; Johnson M; Aboody KS
Neuroimage; 2007; 37 Suppl 1():S18-26. PubMed ID: 17560798
[TBL] [Abstract][Full Text] [Related]
2. Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma.
Kim JH; Lee JE; Kim SU; Cho KG
Neurosurgery; 2010 Feb; 66(2):333-42; discussion 342. PubMed ID: 20087133
[TBL] [Abstract][Full Text] [Related]
3. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
[TBL] [Abstract][Full Text] [Related]
4. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma.
Ehtesham M; Kabos P; Kabosova A; Neuman T; Black KL; Yu JS
Cancer Res; 2002 Oct; 62(20):5657-63. PubMed ID: 12384520
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
6. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.
Li S; Tokuyama T; Yamamoto J; Koide M; Yokota N; Namba H
Cancer Gene Ther; 2005 Jul; 12(7):600-7. PubMed ID: 15775995
[TBL] [Abstract][Full Text] [Related]
7. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
8. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
9. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma.
Shimato S; Natsume A; Takeuchi H; Wakabayashi T; Fujii M; Ito M; Ito S; Park IH; Bang JH; Kim SU; Yoshida J
Gene Ther; 2007 Aug; 14(15):1132-42. PubMed ID: 17508009
[TBL] [Abstract][Full Text] [Related]
10. Stem-cell based therapies for brain tumors.
Yip S; Shah K
Curr Opin Mol Ther; 2008 Aug; 10(4):334-42. PubMed ID: 18683097
[TBL] [Abstract][Full Text] [Related]
11. Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model.
Brekke C; Williams SC; Price J; Thorsen F; Modo M
Neuroimage; 2007 Sep; 37(3):769-82. PubMed ID: 17613248
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered human neural stem cells for brain repair in neurological diseases.
Kim SU
Brain Dev; 2007 May; 29(4):193-201. PubMed ID: 17303360
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells.
Jurvansuu J; Zhao Y; Leung DS; Boulaire J; Yu YH; Ahmed S; Wang S
Cancer Res; 2008 Jun; 68(12):4614-22. PubMed ID: 18559506
[TBL] [Abstract][Full Text] [Related]
14. Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites.
Li S; Gao Y; Tokuyama T; Yamamoto J; Yokota N; Yamamoto S; Terakawa S; Kitagawa M; Namba H
Cancer Lett; 2007 Jun; 251(2):220-7. PubMed ID: 17196326
[TBL] [Abstract][Full Text] [Related]
15. Contact and encirclement of glioma cells in vitro is an intrinsic behavior of a clonal human neural stem cell line.
Khosh N; Brown CE; Aboody KS; Barish ME
PLoS One; 2012; 7(12):e51859. PubMed ID: 23240066
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
[TBL] [Abstract][Full Text] [Related]
17. A novel technique to quantify glioma tumor invasion using serial microscopy sections.
Akella NS; Ding Q; Menegazzo I; Wang W; Gillespie GY; Grammer JR; Gladson CL; Nabors LB
J Neurosci Methods; 2006 Jun; 153(2):183-9. PubMed ID: 16406041
[TBL] [Abstract][Full Text] [Related]
18. Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas.
Wei J; Wahl J; Nakamura T; Stiller D; Mertens T; Debatin KM; Beltinger C
Gene Ther; 2007 Nov; 14(22):1573-86. PubMed ID: 17898797
[TBL] [Abstract][Full Text] [Related]
19. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
20. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4.
Ehtesham M; Yuan X; Kabos P; Chung NH; Liu G; Akasaki Y; Black KL; Yu JS
Neoplasia; 2004; 6(3):287-93. PubMed ID: 15153341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
